Literature DB >> 3797641

Endometrial carcinoma staging by MR imaging.

H Hricak, J L Stern, M R Fisher, L G Shapeero, M L Winkler, C G Lacey.   

Abstract

The potential of magnetic resonance (MR) imaging in the detection of endometrial carcinoma and in the assessment of its extent was evaluated prospectively in 51 patients clinically suspected of having the disease. MR imaging findings were compared with the results of surgical-pathologic staging and lymph node sampling following hysterectomy. Histologic findings showed 45 patients to have endometrial carcinoma, three to have no residual tumor after dilatation and curettage, and three to have adenomatous hyperplasia of the endometrium. MR imaging demonstrated an endometrial abnormality in 43 of the 51 patients (84%). Endometrial carcinoma could not be differentiated from adenomatous hyperplasia or blood clots. Therefore, MR imaging was not specific for tumor detection, and histologic diagnosis remains essential. The overall accuracy of MR imaging in staging endometrial carcinoma was 92%; its overall accuracy in demonstrating the depth of myometrial invasion was 82%. Demonstration of lymphadenopathy and adnexal or peritoneal metastases by MR imaging was suboptimal.

Entities:  

Mesh:

Year:  1987        PMID: 3797641     DOI: 10.1148/radiology.162.2.3797641

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  18 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  Local staging of endometrial carcinoma: role of multidetector CT.

Authors:  A C Tsili; C Tsampoulas; N Dalkalitsis; D Stefanou; E Paraskevaidis; S C Efremidis
Journal:  Eur Radiol       Date:  2008-01-04       Impact factor: 5.315

3.  Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging.

Authors:  K Kinkel; R Forstner; F M Danza; L Oleaga; T M Cunha; A Bergman; J O Barentsz; C Balleyguier; B Brkljacic; J A Spencer
Journal:  Eur Radiol       Date:  2009-02-05       Impact factor: 5.315

4.  A thickened or indistinct junctional zone on T2-weighted MR images in patients with endometrial carcinoma: pathologic consideration based on microcirculation.

Authors:  Yumiko Oishi Tanaka; Masato Nishida; Hajime Tsunoda; Yoshihito Ichikawa; Yukihisa Saida; Yuji Itai
Journal:  Eur Radiol       Date:  2003-01-25       Impact factor: 5.315

5.  Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T.

Authors:  Gilda Rechichi; Stefania Galimberti; Mauro Signorelli; Patrizia Perego; Maria Grazia Valsecchi; Sandro Sironi
Journal:  Eur Radiol       Date:  2009-09-02       Impact factor: 5.315

6.  Surgery in postmenopausal women--the value of transvaginal sonography.

Authors:  A Schoenfeld; H Levavi; J Ovadia
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

Review 7.  Pathophysiology and management of endometrial hyperplasia and carcinoma.

Authors:  Y S Fu; J C Gambone; J S Berek
Journal:  West J Med       Date:  1990-07

8.  The value of MR imaging when the site of uterine cancer origin is uncertain.

Authors:  Hebert Alberto Vargas; Oguz Akin; Junting Zheng; Chaya Moskowitz; Robert Soslow; Nadeem Abu-Rustum; Richard R Barakat; Hedvig Hricak
Journal:  Radiology       Date:  2011-01-06       Impact factor: 11.105

9.  MR imaging in endometrial carcinoma as a diagnostic tool for the prediction of myometrial invasion and lymph node metastasis.

Authors:  Ui Nam Ryoo; Chel Hun Choi; Ji Yeong Yoon; Soo Kyung Noh; Heeseok Kang; Woo Young Kim; Boh Hyun Kim; Tae-Joong Kim; Jeong-Won Lee; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Cancer Res Treat       Date:  2007-12-31       Impact factor: 4.679

Review 10.  MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis.

Authors:  Anita Andreano; Gilda Rechichi; Paola Rebora; Sandro Sironi; Maria Grazia Valsecchi; Stefania Galimberti
Journal:  Eur Radiol       Date:  2014-03-26       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.